1 – 10 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Unraveling the pathophysiology of type 2 diabetes with a new selectively bred animal model, the Oikawa-Nagao mouse
- Contribution to journal › Scientific review
-
Mark
Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II-Associated Non-Islet Cell Tumor Hypoglycemia
- Contribution to journal › Article
- 2024
-
Mark
Evolution of Pleural Solitary Fibrous Tumors Causing Severe Hypoglycemia after Exceptionally Long Asymptomatic Periods : Report of Two Surgical Cases
- Contribution to journal › Article
-
Mark
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes : the SUCRE study
- Contribution to journal › Article
-
Mark
Impact of pemafibrate in patients with metabolic dysfunction-associated steatotic liver disease complicated by dyslipidemia : A single-arm prospective study
- Contribution to journal › Article
-
Mark
HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis
- Contribution to journal › Article
-
Mark
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease : A prospective, multicentre, observational study
- Contribution to journal › Article
- 2023
-
Mark
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
- Contribution to journal › Article
-
Mark
Selectively bred rodent models for studying the etiology of type 2 diabetes : Goto-Kakizaki rats and Oikawa-Nagao mice
- Contribution to journal › Scientific review
-
Mark
Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes : the STREAM study
- Contribution to journal › Article
